Interestingly, PPARγ mutated patients had higher adiponectin levels compared to negative patients; such data is in accordance with previous studies that described higher levels of adiponectin in relation to the PPARγ SNP in several diseases, such as diabetes [37,38]. This evidence concerns the gene ADIPOQ and diabetes mellitus.